[The blood concentration of flurenizid in patients with destructive pulmonary tuberculosis].
Some pharmacokinetic features of new capsulated and tableted antituberculous drug flurenizidum were studied microbiologically in 50 adult patients with advanced pulmonary tuberculosis. Flurenizidum in vitro shows high mycobacteriostatic activity: it suppresses growth of Mycobacteria tuberculosis H37Rv strain in concentration of 0.05 mkg/ml. Single doze of flurenizidum--0.3 and 0.6 g--provided mycobacteriostatic blood concentration for 6 and 12 hours respectively. Maximum concentrations of the drug (0.46 +/- 0.07) mkg/ml and (1.02 +/- 0.14) mkg/ml respectively were observed in 3 hours after administration.